The use of nicorandil in cardioplegia solution

Iida and colleagues [5] reported that ventricular fibrillation improved and disappeared with the start of treatment with nitrates and suggested that CAS should be considered as a differential diagnosis in the presence of ST-segment changes and/or intractable ventricular arrhythmias.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of anaesthesiology 2008-01, Vol.25 (1), p.83-84
Hauptverfasser:	Kiss, G., Gueret, G., Corre, O., Deredec, R., Arvieux, C. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Arrhythmia Agents - administration & dosage Anti-Arrhythmia Agents - adverse effects Anti-Arrhythmia Agents - therapeutic use Cardiology Cardioplegic Solutions Heart attacks Heart surgery Humans Kinases Nicorandil - administration & dosage Nicorandil - adverse effects Nicorandil - therapeutic use Postoperative period
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Iida and colleagues [5] reported that ventricular fibrillation improved and disappeared with the start of treatment with nitrates and suggested that CAS should be considered as a differential diagnosis in the presence of ST-segment changes and/or intractable ventricular arrhythmias.
ISSN:	0265-0215 1365-2346
DOI:	10.1017/S0265021507002621